查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1863096

血管内超音波市场按应用、类型、最终用途和手术方式划分－2025-2032年全球预测

Intravascular Ultrasound Market by Application, Type, End Use, Procedure - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血管内超音波市场将成长至 13.8066 亿美元，复合年增长率为 5.33%。

关键市场统计数据
基准年 2024 9.1095亿美元
预计年份：2025年 9.592亿美元
预测年份 2032 13.8066亿美元
复合年增长率 (%) 5.33%

本文概述了血管内超音波技术的发展历程及其在现代心血管护理中对手术决策和器械选择的影响，并阐述了其在临床应用中的临床意义。

血管内超音波（IVUS）已从研究辅助手段发展成为第一线影像技术，对介入治疗策略和器械选择产生重大影响。声学阵列技术、高解析度成像模式和导管设计的进步缩小了血管内成像与即时手术指导之间的差距，使临床医生能够更自信地观察血管形态、量化斑块负荷并优化器械尺寸。因此，IVUS在复杂的冠状动脉和周边血管介入治疗中发挥日益重要的作用，有助于提高手术精度并可能改善临床疗效。

在医疗保健领域，临床证据、操作人员培训和设备可用性共同推动了血管内超音波（IVUS）技术的应用。与其他互补模式的技术协同作用、支援自动化测量的软体分析以及与导管室工作流程的整合，正在塑造临床医生的预期。同时，监管和报销途径也持续影响采购选择和实施策略。综上所述，这些因素正使IVUS成为相关人员寻求利用成像技术来提升自身价值提案的临床和商业性焦点。

高解析度影像、软体自动化和临床证据产生技术的变革性融合，正在重新定义血管内超音波在介入治疗规划中的作用。

技术创新、不断完善的临床指南以及对手术结果的新期望共同重塑了血管内超音波（IVUS）的模式。射频阵列导管和改进的讯号处理演算法能够更清晰地显示斑块成分和支架阻塞情况，从而减少对透视影像推断的依赖。同时，功能更强大的软体套件能够自动测量管腔和斑块，使操作者能够快速解读结果并产生一致的报告，从而支援标准化的手术终点和结果对比分析。

此外，手术流程的重点正从单纯的解剖学成功转向功能和耐久性指标，这促使临床医生将血管内超音波（IVUS）观察与生理评估和术中决策相结合。这种转变促使供应商提供可与现有导管室系统互通性的平台，并支援资料汇出以用于註册和长期追踪。同时，设备製造商、软体开发人员和临床中心之间建立的伙伴关係生态系统正在加速实证医学证据的产生和应用。这些变革性的变化正在从临床、营运和商业性重新定义IVUS的价值提案。

评估2025年美国关税变化对血管内超音波相关人员的供应链重组、采购多元化和替代商业模式的影响

2025年美国关税调整和贸易政策变化对医疗影像硬体和一次性医疗器材的采购、供应链和定价策略产生了复杂的影响。对于依赖精密设计的导管、客製化换能器材料和主机电子元件的血管内超音波（IVUS）而言，进口关税的增加可能导致到岸成本上升。为此，製造商正优先考虑区域采购多元化、关键零件的近岸生产以及设计改进，以减少对受关税影响的原材料的依赖，同时保持临床性能。

供应链转型不会立即发生，认证、检验和监管备案的前置作业时间会造成时间上的摩擦。因此，医疗服务提供者正在采取分阶段筹资策略和长期服务合约来缓解价格波动。同时，经销商和原始设备製造商 (OEM) 正在探索其他经营模式，例如捆绑式服务产品和基于订阅的主机存取模式，以平稳确认收入并维护客户关係。从创新角度来看，关税正在推动对国内製造能力和本地组装的投资，这可能在长期内增强供应韧性，但也需要谨慎的资本规划和劳动力发展。最终，累积效应正在加速策略性供应链重组，并鼓励医疗服务提供者和供应商之间采用更具创造性的合约方式。

基于细分市场的深刻洞察，将临床应用、设备类型、最终使用环境和手术角色与可操作的产品和商业化重点联繫起来。

深入的細項分析揭示了临床需求、产品设计和采购优先顺序在应用、器械类型、最终用途和手术目的等方面的交汇点。将应用分为冠状动脉和外周血管两大类，并将冠状动脉类进一步细分为急性冠状动脉症候群和慢性完全闭塞，将外周血管类进一步细分为周边动脉疾病和外周静脉应用，结果表明，成像需求会因病变复杂程度、血管大小以及是否需要进行纵向血管评估而有所不同。这些临床差异决定了产品团队优先考虑的导管形状、频率选择和影像处理功能。

同样，对设备类型的分析揭示了不同的价值链和使用者工作流程。阵列导管和单元件导管的分类反映了影像保真度、每次使用成本和相容性之间的权衡。同时，可携式和固定式主机的划分突显了门诊和混合主机对移动性的需求，以及医院导管室对数量和性能的期望。诸如门诊手术中心、医院和研究机构等终端用户环境，有着独特的采购週期、资本核准流程和整合要求，这些都会影响资本支出和一次性用品的采购决策。最后，将手术操作分为诊断功能和引导功能（诊断子类别包括管腔测量和斑块表征，而引导子类别包括动脉粥状硬化斑块切除术辅助和支架置入）有助于明确临床工作流程和证据需求。诊断应用强调定量可重复性和报告，而引导应用则需要即时视觉化、稳健的导管操控性和与治疗设备的整合。整合这些分类轴，可以让公司优先考虑与特定临床用例和买家画像相符的产品特性、临床检验计画和商业化路径。

美洲、欧洲、中东和非洲以及亚太地区的采用模式和战略要务对临床应用和商业化路径的影响

区域趋势对于理解血管内超音波（IVUS）的应用模式和策略重点至关重要。在美洲，临床上对介入性心臟病学创新的重视、针对复杂手术的完善报销机制以及高容量中心的集中分布，都促进了先进成像技术的应用和竞争激烈的服务市场。该地区的监管路径和采购惯例强调可靠的临床结果和经证实的成本效益，这影响供应商如何优先考虑临床证据和上市后监测。

欧洲、中东和非洲地区的医疗格局更为多元化，在医疗资金筹措、先进导管室基础设施的普及以及区域法规结构等方面存在显着差异。应对这种多样性需要采取适应性强的打入市场策略、与当地分销商建立合作关係以及弹性价格设定方式。亚太地区则以其介入治疗能力的快速发展、对本土製造业的投资以及日益活跃的临床研究活动而闻名。该地区的许多医疗系统正在同步加强三级医疗服务能力，并透过门诊服务扩大医疗服务覆盖范围，这为可携式主机和差异化导管设计创造了机会。由于各地区临床实务模式和采购週期存在差异，因此需要製定个人化的证据产生方案和商业模式，以反映当地支付方的期望和实际运作。

竞争与合作的动态表明，硬体领导企业、利基创新者和软体参与企业如何塑造血管内超音波(IVUS) 领域的产品差异化和市场定位。

在血管内超音波（IVUS）领域，能够整合卓越的硬体、软体驱动的分析能力和强大的临床支援的机构仍然占据优势。现有医疗设备製造商利用规模经济、深厚的临床关係和全球分销网络来维持主导地位，而专业的成像创新者则在影像解析度、导管设计和工作流程整合方面展开竞争。新兴参与企业（包括中小型科技公司和软体开发人员）正透过专注于机器学习驱动的斑块分析、自动化报告和云端资料管理来支持多中心註册研究和上市后证据收集，从而挑战传统观念。

与治疗设备製造商签订共同开发契约、授权使用先进的信号处理演算法以及开展基于联盟的临床研究以加速指南采纳等伙伴关係和战略合作正变得日益重要。此外，售后服务、训练项目和手术决策支援工具已成为影响购买决策的差异化因素。成功的公司会平衡研发投入与务实的商业化策略，优先考虑互通性、总体拥有成本以及透过提高手术效率和改善患者预后来提供可证明的临床价值。

针对製造商和医疗服务提供者的具体策略建议包括：证据产生、互通性、供应链韧性和教育计画。这些措施将整合起来，以加速血管内超音波（IVUS）的普及应用。

血管内超音波（IVUS）生态系统中的领导企业应协调对临床证据、产品互通性和供应链韧性的投资，以掌握血管内成像日益增长的作用。首先，企业应优先进行可操作的临床研究，以明确血管内超音波何时能显着改善手术结果，以及对临床医师和支付者而言最重要的指标。此类证据的设计应支持指南的采纳和医保报销的讨论。其次，关注开放标准以及与导管室系统、生理测量平台和电子病历的互通性，将有助于减少推广应用的障碍，并支持收集长期数据以证明其价值。

在营运方面，供应商应实现组件采购多元化，尽可能投资本地製造伙伴关係关係，并提供灵活的商业模式，例如服务包、计量收费和主机订阅。培训仍然至关重要，结合实践模拟、远端监控和数据驱动回馈循环的可扩展培训专案可以加快操作人员的熟练度提升和产品应用。最后，经营团队应促进与治疗设备製造商和软体公司进行有针对性的合作，共同开发整合动脉粥状硬化斑块切除术和支架置入指导的解决方案。这将增强其临床提案，并为整合程度较低的竞争对手设置进入障碍。

本分析所依据的综合调查方法结合了临床医生和工程师的专业知识、一手研究、二手文献综述和技术检验，以确保分析的严谨性和透明性。

本分析所依据的研究结合了与介入性心臟病专家、血管专家、采购人员和器械工程师进行的初步定性研究，以及对临床文献、监管指南和技术评估的严格二次审查。初步研究包括结构化访谈和咨询讨论，旨在确定未满足的临床需求、手术流程和采购决策标准。这些讨论辅以导管设计、感测器架构和主机软体功能的技术评估，以将产品特性与临床应用案例相匹配。

二次研究涵盖了同行评审的临床研究、指南声明和监管文件，旨在检验临床疗效和安全性，而不进行市场规模估算。研究采用数据三角测量技术整合不同资讯并达成共识，同时清楚记录证据不足或不均衡领域的限制。整个研究过程透过专家检验、对受访者进行利益衝突筛检以及遵守有关保密性和知情同意的伦理研究标准，确保了调查方法的严谨性。这种方法确保了研究结果基于当代临床实践和技术可行性，同时也明确指出了需要进一步前瞻性研究的领域。

摘要重点阐述了血管内超音波向重要影像引导工具转型的现状，以及将决定未来主导的策略性倡议。

血管内超音波正处于转折点，技术成熟度、临床需求和商业策略正在融合，推动其在心血管和周边介入治疗中发挥更大的作用。该技术提供的「可操作资讯」使其提案超越了单纯的解剖成像，成为精准治疗计划和检验的基础。随着临床指南和操作者期望的不断演变，相关人员，将能够引领该技术的应用普及。

展望未来，区域医疗保健趋势、供应链协调以及软体驱动的分析之间的相互作用将决定哪些应用和设备配置将最为普及。对互通性和整合式手术解决方案的策略性投资将使企业脱颖而出，而加速临床检验和报销流程的伙伴关係将释放更广泛的临床效用。简而言之，血管内超音波（IVUS）正从一种专业辅助手段转变为介入医师寻求可重复影像导引治疗结果的必备工具。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 大型医院越来越多地采用三维和即时容积式血管内超音波系统
  • 利用血管内超音波结合人工智慧演算法实现斑块自动表征
  • 开发用于全面评估冠状动脉病变的混合型血管内超音波-光学相干断层扫描导管
  • 血管内超音波导引治疗在复杂慢性完全闭塞病例的应用日益广泛
  • 扩展与血管内超音波（IVUS）相容的光纤感测器，实现高解析度影像重现性
  • 设备製造商和软体公司合作推进血管内超音波（IVUS）影像分析
  • 保险审批核准的增加推动了血管内超音波设备在临床上的广泛应用
  • 专注于用于週边和神经血管应用的小型化IVUS导管

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 血管内超音波市场：依应用领域划分

  • 冠状动脉
    • 急性冠状动脉症候群
    • 慢性完全闭塞
  • 外围
    • 周边动脉疾病
    • 週边静脉应用

9. 血管内超音波市场（按类型划分）

  • 导管
    • 阵列导管
    • 单元件导管
  • 主机
    • 可携式主机
    • 固定主机

第十章 血管内超音波市场：依最终用途划分

  • 门诊手术中心
  • 医院
  • 研究所

第十一章 血管内超音波市场（依手术类型划分）

  • 诊断
    • 管腔测量
    • 斑块特征
  • 指导
    • 动脉粥状硬化斑块切除术支持
    • 支架置入

第十二章 血管内超音波市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 血管内超音波市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国血管内超音波市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Koninklijke Philips NV
    • Boston Scientific Corporation
    • Siemens Healthineers AG
    • General Electric Company
    • Abbott Laboratories
    • Canon Medical Systems Corporation
    • Terumo Corporation
    • ACIST Medical Systems, Inc.
    • InfraReDx, Inc.
Product Code: MRR-F6513A06BEE8

The Intravascular Ultrasound Market is projected to grow by USD 1,380.66 million at a CAGR of 5.33% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 910.95 million
Estimated Year [2025] USD 959.20 million
Forecast Year [2032] USD 1,380.66 million
CAGR (%) 5.33%

Foundational overview of intravascular ultrasound developments and clinical integration shaping procedural decision-making and device selection in contemporary cardiovascular care

Intravascular ultrasound (IVUS) has evolved from an investigational adjunct to a frontline imaging modality that materially influences interventional strategy and device selection. Recent advances in acoustic array technology, higher-resolution imaging modes, and improved catheter designs have narrowed the gap between intravascular imaging and real-time procedural guidance, enabling clinicians to visualize vessel morphology, quantify plaque burden, and optimize device sizing with greater confidence. As a result, IVUS increasingly factors into complex coronary and peripheral interventions, supporting improved procedural precision and potentially better clinical outcomes.

Across care settings, adoption is driven by a combination of clinical evidence, operator training, and equipment accessibility. Technological synergies with complementary modalities, software-enabled analytics for automated measurements, and integration with cath lab workflows are shaping clinician expectations. Simultaneously, regulatory scrutiny and reimbursement pathways continue to influence procurement choices and deployment strategies. Taken together, these factors establish IVUS as both a clinical and commercial focal point for stakeholders seeking to differentiate through imaging-enabled value propositions.

Transformative convergence of higher-resolution imaging, software automation, and clinical evidence generation that is redefining the role of intravascular ultrasound in intervention planning

The IVUS landscape is being reshaped by a convergence of technology innovation, shifting clinical guidelines, and new expectations for procedural outcomes. High-frequency array catheters and improved signal processing algorithms now permit clearer delineation of plaque components and stent apposition, reducing reliance on fluoroscopic inference. Concurrently, enhanced software suites that provide automated lumen and plaque metrics are enabling faster interpretation and consistent reporting across operators, which supports standardized procedural endpoints and comparative outcomes analysis.

Moreover, procedural emphasis has migrated from purely anatomical success to functional and durability metrics, prompting clinicians to integrate IVUS findings with physiological assessments and intraprocedural decision-making. This shift encourages vendors to offer platforms that are interoperable with existing cath lab systems and that support data export for registries and longitudinal follow-up. In parallel, an ecosystem of partnerships between device manufacturers, software developers, and clinical centers is accelerating evidence generation and adoption. Taken together, these transformative shifts are redefining value propositions for IVUS across clinical, operational, and commercial dimensions.

Assessment of how 2025 United States tariff shifts have catalyzed supply chain realignment, sourcing diversification, and alternative commercial models for intravascular ultrasound stakeholders

Tariff adjustments and trade policy changes introduced in the United States in 2025 have exerted a complex influence on procurement, supply chains, and pricing strategies for medical imaging hardware and disposable devices. For IVUS, which relies on precision-engineered catheters, custom transducer materials, and console electronics, increased import duties can elevate landed costs. In response, manufacturers have prioritized regional sourcing diversification, nearshoring of key components, and redesigns that reduce dependency on tariff-affected inputs while preserving clinical performance.

Transitioning supply chains is not instantaneous; lead times for qualification, validation, and regulatory submission impose temporal friction. Consequently, healthcare providers have adopted staged purchasing strategies and longer-term service agreements to mitigate price volatility. At the same time, distributors and OEMs have explored alternative commercial models, including bundled service offerings and subscription-based access to consoles, to smooth revenue recognition and maintain customer relationships. From an innovation perspective, tariffs have incentivized investment in domestic manufacturing capacity and local assembly, which over time may strengthen supply resilience but also require careful capital planning and workforce development. Ultimately, the cumulative impact has been to accelerate strategic supply chain realignment while prompting more creative contracting approaches between providers and vendors.

Compelling segmentation-driven insights that link clinical applications, device typologies, end-use environments, and procedural roles to actionable product and commercialization priorities

Insightful segmentation analysis reveals where clinical demand, product design, and procurement priorities intersect across application, device type, end use, and procedural purpose. When applications are parsed into coronary and peripheral domains, with coronary further distinguished by acute coronary syndrome and chronic total occlusion and peripheral use differentiated into peripheral artery disease and peripheral venous applications, it becomes clear that imaging requirements diverge by lesion complexity, vessel size, and the need for longitudinal vessel assessment. These clinical distinctions drive catheter geometry, frequency selection, and image processing features that product teams prioritize.

Similarly, examining device type illuminates differing value chains and user workflows. Catheters split into array catheters and single element catheters reflect trade-offs between image fidelity, cost per use, and compatibility, while console segmentation into portable and stationary consoles highlights the demand for mobility in ambulatory and hybrid settings versus the capacity and performance expectations in hospital cath labs. End-use environments such as ambulatory surgical centers, hospitals, and research institutes each impose unique procurement cycles, capital approval processes, and integration requirements, which in turn influence decisions on capital expenditure versus disposable purchases. Finally, procedural segmentation into diagnostic and guidance functions-where diagnostic subcategories include lumen measurement and plaque characterization, and guidance subcategories include atherectomy support and stent placement-clarifies clinical workflows and evidence needs. Diagnostic applications emphasize quantitative reproducibility and reporting, while guidance applications demand real-time visualization, robust catheter handling, and integration with therapeutic devices. By synthesizing these axes of segmentation, companies can prioritize product features, clinical validation plans, and commercialization pathways aligned to specific clinical use cases and buyer profiles.

Regional adoption patterns and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence clinical uptake and commercialization pathways

Regional dynamics are critical to understanding adoption patterns and strategic priorities for IVUS. In the Americas, clinical emphasis on interventional cardiology innovation, well-established reimbursement frameworks for complex procedures, and a concentration of high-volume centers have supported advanced imaging adoption and a competitive service market. Regulatory pathways and procurement practices in the region place a premium on robust clinical outcomes and cost-effectiveness demonstrations, which influences how vendors prioritize clinical evidence and post-market surveillance.

In Europe, Middle East & Africa, the landscape is more heterogeneous, with marked variation in healthcare funding, access to advanced cath lab infrastructure, and local regulatory frameworks. This heterogeneity requires adaptive market entry strategies, partnerships with regional distributors, and flexible pricing approaches. In the Asia-Pacific region, rapid expansion of interventional capabilities, investment in domestic manufacturing, and growing clinical research activity are notable. Many health systems in that region are simultaneously building capacity in tertiary centers and broadening access through ambulatory settings, creating opportunities for both portable consoles and differentiated catheter designs. Across regions, differences in clinical practice patterns and procurement cycles necessitate tailored evidence generation and commercial models that reflect local payer expectations and operational realities.

Competitive and collaborative dynamics showing how hardware leaders, niche innovators, and software entrants are shaping product differentiation and market positioning in intravascular ultrasound

Competitive dynamics in the IVUS space continue to favor organizations that can integrate hardware excellence with software-enabled analytics and strong clinical support. Established medical device firms often leverage scale, deep clinical relationships, and global distribution networks to maintain leadership, while specialized imaging innovators compete on image resolution, catheter design, and workflow integration. Emerging entrants-including small-cap technology firms and software developers-are challenging conventions by focusing on machine learning-driven plaque analysis, automated reporting, and cloud-enabled data management that supports multicenter registries and post-market evidence collection.

Partnerships and strategic collaborations are increasingly important, whether through co-development agreements with therapeutic device manufacturers, licensing of advanced signal-processing algorithms, or consortium-based clinical studies that accelerate guideline inclusion. In addition, aftermarket services, training programs, and procedural decision-support tools have become differentiators that influence purchasing decisions. Successful companies balance investment in R&D with pragmatic commercialization strategies that prioritize interoperability, total cost of ownership considerations, and demonstrable clinical value delivered through improved procedural efficiency and patient outcomes.

Actionable strategic recommendations for manufacturers and providers to align evidence generation, interoperability, supply resilience, and education programs to accelerate intravascular ultrasound adoption

Leaders in the IVUS ecosystem should align investments across clinical evidence, product interoperability, and supply chain resilience to capture the expanding role of intravascular imaging. First, companies must prioritize pragmatic clinical studies that clarify when intravascular ultrasound materially improves procedural outcomes and which metrics matter most to operators and payers; such evidence should be designed to support guideline inclusion and reimbursement discussions. Second, focusing on open standards and interoperability with cath lab systems, physiologic measurement platforms, and electronic health records will lower barriers to adoption and support longitudinal data capture for value demonstration.

Operationally, vendors should diversify component sourcing, invest in regional manufacturing partnerships where feasible, and offer flexible commercial models that include service bundles, pay-per-use, or subscription options for consoles. Training and education remain critical; therefore, scalable programs that combine hands-on simulation, remote proctoring, and data-driven feedback loops will accelerate operator proficiency and adoption. Finally, executives should pursue targeted collaborations with therapeutic device manufacturers and software firms to co-create integrated solutions for guidance during atherectomy and stent placement, thereby strengthening clinical propositions and creating barrier-to-entry effects against less integrated competitors.

Comprehensive research methodology blending primary clinician and engineering insights with secondary literature review and technical validation to ensure rigorous, transparent analysis

The research underpinning this analysis synthesizes primary qualitative engagement with interventional cardiologists, vascular specialists, procurement leaders, and device engineers alongside rigorous secondary review of clinical literature, regulatory guidance, and technology assessments. Primary inputs included structured interviews and advisory discussions designed to uncover unmet clinical needs, procedural workflows, and procurement decision criteria. These conversations were complemented by technical assessments of catheter designs, transducer architectures, and console software capabilities to map product feature sets against clinical use cases.

Secondary research included peer-reviewed clinical studies, guideline statements, and regulatory documentation to validate clinical efficacy and safety considerations without extrapolating market volumes. Data triangulation techniques were applied to reconcile disparate inputs and surface consensus views, while limitations were clearly documented where evidence is emerging or heterogeneous. Throughout the process, methodological rigor was maintained through expert validation rounds, conflict-of-interest screening for interview participants, and adherence to ethical research standards for confidentiality and informed consent. This approach ensures that findings are grounded in contemporary clinical practice and technical feasibility while being transparent about areas that warrant further prospective study.

Concluding synthesis that highlights intravascular ultrasound's transition to an indispensable image-guided tool and the strategic actions that determine future leadership

Intravascular ultrasound stands at an inflection point where technological maturity, clinical expectations, and commercial strategy converge to expand its role in cardiovascular and peripheral interventions. The modality's capacity to provide actionable intraprocedural information has elevated its value proposition beyond anatomical imaging to a cornerstone of precision therapy planning and verification. As clinical guidelines and operator expectations evolve, stakeholders who align product innovation with pragmatic evidence generation, robust training, and flexible commercial models will be positioned to lead adoption curves.

Looking forward, the interplay of regional healthcare dynamics, supply chain adjustments, and software-driven analytics will determine which applications and device configurations gain the most traction. Strategic investments in interoperability and integrated procedural solutions will differentiate winners from followers, while partnerships that accelerate clinical validation and reimbursement pathways will unlock broader clinical utility. In sum, IVUS is transitioning from a specialized adjunct to an indispensable tool for interventionalists seeking reproducible, image-guided outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of 3D and real-time volumetric IVUS systems by leading hospitals
  • 5.2. Integration of artificial intelligence algorithms for automated plaque characterization using IVUS
  • 5.3. Development of hybrid IVUS-OCT catheters for comprehensive coronary lesion assessment
  • 5.4. Growing utilization of IVUS guidance in complex chronic total occlusion interventions
  • 5.5. Expansion of IVUS-compatible fiber-optic sensors enabling higher resolution imaging fidelity
  • 5.6. Partnerships between device manufacturers and software firms to enhance IVUS image analysis
  • 5.7. Increasing reimbursement approvals driving broader clinical adoption of IVUS devices
  • 5.8. Focus on miniaturized IVUS catheters for peripheral vascular and neurovascular applications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravascular Ultrasound Market, by Application

  • 8.1. Coronary
    • 8.1.1. Acute Coronary Syndrome
    • 8.1.2. Chronic Total Occlusion
  • 8.2. Peripheral
    • 8.2.1. Peripheral Artery Disease
    • 8.2.2. Peripheral Venous Applications

9. Intravascular Ultrasound Market, by Type

  • 9.1. Catheters
    • 9.1.1. Array Catheters
    • 9.1.2. Single Element Catheters
  • 9.2. Consoles
    • 9.2.1. Portable Consoles
    • 9.2.2. Stationary Consoles

10. Intravascular Ultrasound Market, by End Use

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Research Institutes

11. Intravascular Ultrasound Market, by Procedure

  • 11.1. Diagnostic
    • 11.1.1. Lumen Measurement
    • 11.1.2. Plaque Characterization
  • 11.2. Guidance
    • 11.2.1. Atherectomy Support
    • 11.2.2. Stent Placement

12. Intravascular Ultrasound Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intravascular Ultrasound Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intravascular Ultrasound Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Koninklijke Philips N.V.
    • 15.3.2. Boston Scientific Corporation
    • 15.3.3. Siemens Healthineers AG
    • 15.3.4. General Electric Company
    • 15.3.5. Abbott Laboratories
    • 15.3.6. Canon Medical Systems Corporation
    • 15.3.7. Terumo Corporation
    • 15.3.8. ACIST Medical Systems, Inc.
    • 15.3.9. InfraReDx, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTRAVASCULAR ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTRAVASCULAR ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAVASCULAR ULTRASOUND MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STATIONARY CONSOLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY LUMEN MEASUREMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PLAQUE CHARACTERIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ATHERECTOMY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY STENT PLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CONSOLES, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PROCEDURE, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 307. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2024 (USD MILLION)
  • TABLE 312. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2025-2032 (USD MILLION)
  • TABLE 313. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2024 (USD MILLION)
  • TABLE 314. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY TYPE, 2025-2032 (